SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization
- Author
- Nele Festjens (UGent) , Kristof Vandewalle, Erica Houthuys (UGent) , Evelyn Plets (UGent) , Dieter Vanderschaeghe (UGent) , Katlyn Borgers, Annelies Van Hecke (UGent) , Petra Tiels (UGent) and Nico Callewaert (UGent)
- Organization
- Keywords
- Tuberculosis, Vaccine, SapM, Immunomodulation, GUINEA-PIG MODEL, MYCOBACTERIUM-TUBERCULOSIS, PROTECTIVE IMMUNITY, IN-VITRO, METAANALYSIS, MENINGITIS, CHALLENGE, RESPONSES, EFFICACY, STRAINS
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 2.98 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8619697
- MLA
- Festjens, Nele, et al. “SapM Mutation to Improve the BCG Vaccine : Genomic, Transcriptomic and Preclinical Safety Characterization.” VACCINE, vol. 37, no. 27, 2019, pp. 3539–51, doi:10.1016/j.vaccine.2019.05.022.
- APA
- Festjens, N., Vandewalle, K., Houthuys, E., Plets, E., Vanderschaeghe, D., Borgers, K., … Callewaert, N. (2019). SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization. VACCINE, 37(27), 3539–3551. https://doi.org/10.1016/j.vaccine.2019.05.022
- Chicago author-date
- Festjens, Nele, Kristof Vandewalle, Erica Houthuys, Evelyn Plets, Dieter Vanderschaeghe, Katlyn Borgers, Annelies Van Hecke, Petra Tiels, and Nico Callewaert. 2019. “SapM Mutation to Improve the BCG Vaccine : Genomic, Transcriptomic and Preclinical Safety Characterization.” VACCINE 37 (27): 3539–51. https://doi.org/10.1016/j.vaccine.2019.05.022.
- Chicago author-date (all authors)
- Festjens, Nele, Kristof Vandewalle, Erica Houthuys, Evelyn Plets, Dieter Vanderschaeghe, Katlyn Borgers, Annelies Van Hecke, Petra Tiels, and Nico Callewaert. 2019. “SapM Mutation to Improve the BCG Vaccine : Genomic, Transcriptomic and Preclinical Safety Characterization.” VACCINE 37 (27): 3539–3551. doi:10.1016/j.vaccine.2019.05.022.
- Vancouver
- 1.Festjens N, Vandewalle K, Houthuys E, Plets E, Vanderschaeghe D, Borgers K, et al. SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization. VACCINE. 2019;37(27):3539–51.
- IEEE
- [1]N. Festjens et al., “SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization,” VACCINE, vol. 37, no. 27, pp. 3539–3551, 2019.
@article{8619697,
author = {{Festjens, Nele and Vandewalle, Kristof and Houthuys, Erica and Plets, Evelyn and Vanderschaeghe, Dieter and Borgers, Katlyn and Van Hecke, Annelies and Tiels, Petra and Callewaert, Nico}},
issn = {{0264-410X}},
journal = {{VACCINE}},
keywords = {{Tuberculosis,Vaccine,SapM,Immunomodulation,GUINEA-PIG MODEL,MYCOBACTERIUM-TUBERCULOSIS,PROTECTIVE IMMUNITY,IN-VITRO,METAANALYSIS,MENINGITIS,CHALLENGE,RESPONSES,EFFICACY,STRAINS}},
language = {{eng}},
number = {{27}},
pages = {{3539--3551}},
title = {{SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization}},
url = {{http://doi.org/10.1016/j.vaccine.2019.05.022}},
volume = {{37}},
year = {{2019}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: